Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrochemotherapy of Head and Neck Cancer
2013-002723-42Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bleomycin in head and neck cancer (HNC), sponsored by Rigshospitalet. Primary endpoint: Tumor response in the treated target lesion. Started Aug 2013; status: completed.
02
Drugs
bleomycin
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on 2013-002723-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002723-42.